Advertisement
Organisation › Details
Abbott Arzneimittel GmbH
![]() |
Start | 2011-08-17 renamed before |
| Group | Abbott (Group) | |
| Predecessor | Solvay Arzneimittel GmbH | |
![]() |
Industry | enzyme replacement therapeutic |
![]() |
Region | Neustadt am Rübenberge |
| Country | Germany | |
| Street | 33 Justus-von-Liebig-Str. | |
| City | 31535 Neustadn am Rübenberge | |
| Address record changed: 2011-08-17 | ||
| Basic data | Employees | n. a. |
Record changed: 2011-11-25 |
Advertisement
More documents for Abbott (Group)
- [1] CellaVision AB. (2/25/13). "Press Release: CellaVision Adds another Distribution Agreement for the European Market"....
- [2] Abbott. (1/2/13). "Press Release: Abbott Completes Separation of Research-based Pharmaceuticals Business". Abbott Park, IL....
- [3] Galapagos N.V.. (11/16/12). "Press Release: Galapagos Business Update". Mechelen....
- [4] Medigene AG. (11/8/12). "Press Release: Medigene Announces Market Launch of Veregen in Switzerland and Market Approval in 8 Additional European Countries". Martinsried....
- [5] Galapagos N.V.. (8/3/12). "Press Release: Galapagos Delivers Solid Half year Results 2012. Patients for GLPG0634 Phase 2a Study Now Fully Recruited". Mechelen....
- [6] Biotest AG. (3/22/12). "Press Release: Biotest Reached an All-time High Profit after Tax". Dreieich....
- [7] Biotest AG. (3/22/12). "Press Release: Presentation. Press and Analyst Conference – Financial Year 2011". Dreieich....
- [8] Abbott Laboratories Inc.. (3/2/12). "Press Release: Abbott’s Starlims Business Acquires Distribution Partners to Build International Presence". Abbott Park, IL....
- [9] Galapagos N.V.. (3/2/12). "Press Release: Pipeline Promise Confirmed. Mixed Financial Results for 2011, but with Excellent Outlook for 2012". Mechelen....
- [10] Galapagos N.V.. (2/29/12). "Press Release: Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases. Selective JAK1 Inhibitor in Phase 2 Clinical Development for Rheumatoid Arthritis"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2011.jpg)









![Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)